Show simple item record

dc.contributor.authorDRAHOS, Peter
dc.date.accessioned2021-06-03T12:15:47Z
dc.date.available2021-06-03T12:15:47Z
dc.date.issued2021
dc.identifier.issn1725-6739
dc.identifier.urihttps://hdl.handle.net/1814/71560
dc.description.abstractThe paper examines three decades of the history of patents and pandemics that begins with the HIV/AIDS pandemic and TRIPS. This history demonstrates that the patent system is itself a huge source of risk when it comes to managing the risks of pandemics. From this history ten core lessons are extracted. The central message of the paper is that developing countries will have to focus on collaborations among themselves with the aim of building a wide base of rich manufacturing experience in the production of medicines and therapies. They can expect no priority of treatment under the present patent-mediated response to pandemics.en
dc.format.mimetypeapplication/pdfen
dc.language.isoenen
dc.publisherEuropean University Instituteen
dc.relation.ispartofseriesEUI LAWen
dc.relation.ispartofseries2021/05en
dc.rightsinfo:eu-repo/semantics/openAccessen
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.subjectCOVID-19en
dc.subjectPandemic Risken
dc.subjectPatentsen
dc.subjectTRIPSen
dc.subjectVaccinesen
dc.titlePublic lies and public goods : ten lessons from when patents and pandemics meeten
dc.typeWorking Paperen
dc.rights.licenseAttribution 4.0 International*


Files associated with this item

Icon
Icon

This item appears in the following Collection(s)

Show simple item record

Attribution 4.0 International
Except where otherwise noted, this item's license is described as Attribution 4.0 International